Glatiramer acetate

When ATH:
L04AX13

Characteristic.

Acetate salt of synthetic polypeptides, formed by four natural amino acids (L-glutamic acid, L-alanine, L-tyrosine and L-lysine); by chemical structure has similarities to myelin basic protein.

Pharmacological action.
Immunomodulatory.

Application.

Multiple sclerosis relapsing-remitting course.

Contraindications.

Hypersensitivity, incl. to mannitol.

Restrictions apply.

Pregnancy, lactation, childhood (Safety and efficacy of aged 18 years to be determined).

Pregnancy and breast-feeding.

Maybe, if the effect of therapy outweighs the potential risk to the fetus and child (adequate and well-controlled studies of the safety of use in pregnant and lactating women have not performed).

Category actions result in FDA - B. (The study of reproduction in animals revealed no risk of adverse effects on the fetus, and adequate and well-controlled studies in pregnant women have not done.)

Side effects.

Vasodilation, hyperemia, pain or heaviness in the chest, heartbeat, increased blood pressure, anxiety / anxiety, weakness, breathlessness, nausea, difficulty weight management, arthralgia, lymphadenopathy, hives (It occurs immediately after the injection approximately 10% cases, are their own and do not require special treatment).

Local reactions: soreness at the injection site, redness, edema, itch.

Cooperation.

Compatible with glucocorticoids.

Dosing and Administration.

P /, 20 mg 1 once daily at one and the same time. Treatment long.